Comparison of the Effectiveness of Lifestyle Modification with Other Treatments on the Incidence of Type 2 Diabetes in People at High Risk: A Network Meta-Analysis

被引:18
作者
Yamaoka, Kazue [1 ]
Nemoto, Asuka [1 ]
Tango, Toshiro [1 ,2 ]
机构
[1] Teikyo Univ, Grad Sch Publ Hlth, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan
[2] Ctr Med Stat, Minato Ku, 2-9-6 Shiodome Italia Gai Siodome First 4F, Tokyo 1050021, Japan
关键词
systematic review; network meta-analysis; randomized controlled trial; high risk of type 2 diabetes; lifestyle modification; diet; medication; IMPAIRED GLUCOSE-TOLERANCE; RANDOMIZED CONTROLLED-TRIAL; DOUBLE-BLIND; JAPANESE INDIVIDUALS; EDUCATION-PROGRAM; PUBLICATION BIAS; PREVENTION; INTERVENTION; PROGRESSION; MELLITUS;
D O I
10.3390/nu11061373
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Many clinical trials have been conducted to verify the effects of interventions for prevention of type 2 diabetes (T2D) using different treatments and outcomes. The aim of this study was to compare the effectiveness of lifestyle modifications (LM) with other treatments in persons at high risk of T2D by a network meta-analysis (NMA). Methods: Searches were performed of PUBMED up to January 2018 to identify randomized controlled trials. The odds ratio (OR) with onset of T2D at 1 year in the intervention group (LM, dietary, exercise, or medication) versus a control group (standard treatments or placebo) were the effect sizes. Frequentist and Bayesian NMAs were conducted. Results: Forty-seven interventions and 12 treatments (20,113 participants) were used for the analyses. The OR in the LM was approximately 0.46 (95% CI: 0.33 to 0.61) times lower compared to the standard intervention by the Bayesian approach. The effects of LM compared to other treatments by indirect comparisons were not significant. Conclusions: This meta-analysis further strengthened the evidence that LM reduces the onset of T2D compared to standard and placebo interventions and appears to be at least as effective as nine other treatments in preventing T2D.
引用
收藏
页数:13
相关论文
共 65 条
  • [1] [Anonymous], 2012, TYPE 2 DIAB PREV PEO
  • [2] [Anonymous], 2019, NAT DIAB PREV PROGR
  • [3] [Anonymous], ZHONGGUO LINCHUANG K
  • [4] [Anonymous], DIAB ACT
  • [5] [Anonymous], COCHRANE DB SYST REV
  • [6] Physical activity and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis
    Aune, Dagfinn
    Norat, Teresa
    Leitzmann, Michael
    Tonstad, Serena
    Vatten, Lars Johan
    [J]. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2015, 30 (07) : 529 - 542
  • [7] Bosch J, 2006, NEW ENGL J MED, V355, P1551
  • [8] Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management
    Chaudhury, Arun
    Duvoor, Chitharanjan
    Dendi, Vijaya Sena Reddy
    Kraleti, Shashank
    Chada, Aditya
    Ravilla, Rahul
    Marco, Asween
    Shekhawat, Nawal Singh
    Montales, Maria Theresa
    Kuriakose, Kevin
    Sasapu, Appalanaidu
    Beebe, Alexandria
    Patil, Naveen
    Musham, Chaitanya K.
    Lohani, Govinda Prasad
    Mirza, Wasique
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2017, 8
  • [9] Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial
    Chiasson, JL
    Josse, RG
    Gomis, R
    Hanefeld, M
    Karasik, A
    Laakso, M
    [J]. LANCET, 2002, 359 (9323) : 2072 - 2077
  • [10] DASH Dietary Pattern and Cardiometabolic Outcomes: An Umbrella Review of Systematic Reviews and Meta-Analyses
    Chiavaroli, Laura
    Viguiliouk, Effie
    Nishi, Stephanie K.
    Mejia, Sonia Blanco
    Rahelic, Dario
    Kahleova, Hana
    Salas-Salvado, Jordi
    Kendall, Cyril W. C.
    Sievenpiper, John L.
    [J]. NUTRIENTS, 2019, 11 (02)